SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-175532
Filing Date
2013-04-26
Accepted
2013-04-26 07:08:05
Documents
8
Period of Report
2013-06-07
Effectiveness Date
2013-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d524399ddef14a.htm DEF 14A 309378
2 GRAPHIC g524399g31w82.jpg GRAPHIC 7035
3 GRAPHIC g524399g49y48.jpg GRAPHIC 60086
4 GRAPHIC g524399g55m44.jpg GRAPHIC 19093
5 GRAPHIC g524399g68r34.jpg GRAPHIC 8314
6 GRAPHIC g524399g87z50.jpg GRAPHIC 28635
7 GRAPHIC g524399g95s87.jpg GRAPHIC 58845
8 GRAPHIC g524399g96w12.jpg GRAPHIC 51050
  Complete submission text file 0001193125-13-175532.txt   632590
Mailing Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581
Business Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-54910 | Film No.: 13784706
SIC: 2834 Pharmaceutical Preparations